|
WO2015165374A1
|
|
Methods and compositions for modulating the immune system with arginase i
|
|
CN103402537A
|
|
Use of pegylated recombinant human arginase for treatment of leukemia
|
|
CN101357986A
|
|
Polyethylene glycol functional derivatives and manufacturing method thereof
|
|
WO2007107929A1
|
|
Method and composition for protection against radiation
|
|
US2008138858A1
|
|
Expression System for Recombinant Human Arginase I
|
|
WO2006058486A1
|
|
Use of arginase in combination with 5fu and other compounds for treatment of human malignancies
|
|
KR20070100875A
|
|
Pharmaceutical composition and method of treating hepatitis with arginases
|
|
TW200615000A
|
|
Use of arginase for the treatment of hepatitis
|
|
TWI331531B
|
|
Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation
|
|
WO2004000349A1
|
|
Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation
|
|
HK1053577A2
|
|
Pharmaceutical composition and method of treatment of human malignanices with arginine deprivation
|
